法国人口老龄化给放射治疗师带来了治疗老年患者和调整治疗方法的挑战。不可思议的30年前,如今,90岁以上的患者受到放射治疗的关注。在过去的几年中,老年病量表得到了改进,但不一定要确保正确的治疗给予正确的患者:如果老年病量表的使用影响最终的治疗决定,它不定义新的目标卷,新剂量,或新的分馏方案。除了一些器官,没有,目前,关于老年人群适应治疗的任何共识。这使得任何治疗决策都很困难。本综述旨在了解有关老年人(>70岁)或极老年人(>90岁)人群中放射治疗的有利和不利影响的研究报告。
The ageing of French population imposes to radiotherapists the challenge to treat older patients and to adjust their treatment. Unthinkable 30 years ago, radiation therapy concerns nowadays patients aged more than 90 years old. Oncogeriatric scales have been improved those last years without necessarily making sure that the right treatment is given to the right patient: if oncogeriatric scales use influences the final therapeutic decision, it does not define new target volumes, new doses, or new fractionation protocols. Except for some organs, there is not, for the moment, any consensus concerning geriatric population adapted treatments. This makes any therapeutic decision difficult. The present
review has for objective to realise a report of the studies about favorable and unfavorable effects of radiation therapy amongst aged (>70 years old) or very aged (>90years old) population.